Sam Brusco, Associate Editor06.27.22
Arrhythmia management firm Acutus Medical has launched an expanded suite of left-heart access products to now include the AcQCross Qx system for use with the TruSeal and FXD delivery system for the Watchman LAAC device.
AcQCross is a transseptal system with an integrated needle and dilator to reduce exchange of wires and needles when trying to achieve the right angle and location on the septum.
“Crossing the septum at the proper location is important when doing any left-sided heart procedure, but it can be especially critical to the success of delivering Watchman to the left atrial appendage,” Dr. Tom Waggoner, DO, FACC, FSCAI, FSVM, RPVI, Director, Structural Heart Program and Cardiovascular Research, Tucson Medical Center, told the press. “With AcQCross, I can easily reposition without withdrawing or exchanging needles or wires, so its new compatibility with Watchman has made my procedures much safer for my patients and far more efficient for me and my team.”
AcQCross’ array of catheters are length-, diameter-, and tip-matched and lock into the hub of market-leading sheaths used in a majority of left-heart procedures. Using AcQCross lets physicians use preferred sheaths in virtually any left-heart access procedure.
“The AcQCross system provides interventional cardiologists and electrophysiologists with unique benefits of broad compatibility with market-leading access sheaths while also enhancing procedure versatility and workflow,” said David Roman, interim CEO and CFO, Acutus Medical. “The expanded AcQCross product line allows us to bring this innovative technology to a wider range of procedure categories that should drive sustained growth in this portfolio.”
AcQCross is a transseptal system with an integrated needle and dilator to reduce exchange of wires and needles when trying to achieve the right angle and location on the septum.
“Crossing the septum at the proper location is important when doing any left-sided heart procedure, but it can be especially critical to the success of delivering Watchman to the left atrial appendage,” Dr. Tom Waggoner, DO, FACC, FSCAI, FSVM, RPVI, Director, Structural Heart Program and Cardiovascular Research, Tucson Medical Center, told the press. “With AcQCross, I can easily reposition without withdrawing or exchanging needles or wires, so its new compatibility with Watchman has made my procedures much safer for my patients and far more efficient for me and my team.”
AcQCross’ array of catheters are length-, diameter-, and tip-matched and lock into the hub of market-leading sheaths used in a majority of left-heart procedures. Using AcQCross lets physicians use preferred sheaths in virtually any left-heart access procedure.
“The AcQCross system provides interventional cardiologists and electrophysiologists with unique benefits of broad compatibility with market-leading access sheaths while also enhancing procedure versatility and workflow,” said David Roman, interim CEO and CFO, Acutus Medical. “The expanded AcQCross product line allows us to bring this innovative technology to a wider range of procedure categories that should drive sustained growth in this portfolio.”